0 Comments
0 Shares
107 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
GLP-1 Diet Food Market Growth 2036 with Nestlé, Conagra, Danone, Huel & ADMNEWARK, Del., USA | May 6, 2026 — According to the latest market analysis by Future Market Insights (FMI), the global GLP-1 diet food market is entering a rapid expansion phase as changing consumer eating behavior—driven by GLP-1 weight-management therapies—reshapes demand for portion-controlled, nutrient-dense food products. Food manufacturers are increasingly aligning...0 Comments 0 Shares 504 Views 0 Reviews
-
GLP-1 Market Expands with Oral Formulations, Biologics and Cardiometabolic ApplicationsGLP-1 Market to Reach USD 133.92 Billion by 2034, Growing at 10.9% CAGR: Polaris Market Research According to Polaris Market Research, the global GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034. The market is estimated at USD 58.48 billion in 2026 and is expected to grow at a CAGR of 10.9% during 2026–2034. Expansion is being...0 Comments 0 Shares 215 Views 0 Reviews
-
GLP-1 Meal Replacement Market Size to Reach USD 10.9 Billion by 2036, Driven by Ready-to-Drink Shakes, High-Protein Focus, and Reduced-Appetite Nutrition NeedsThe global GLP-1 meal replacement market was valued at USD 2.4 billion in 2026. The market is projected to reach USD 10.9 billion by 2036, expanding at a CAGR of 16.3% from 2026 to 2036. The market is expected to create an incremental opportunity of USD 8.5 billion over the forecast period. Future Market Insights' analysis of the GLP-1 meal replacement market provides investors,...0 Comments 0 Shares 394 Views 0 Reviews
-
GLP-1 Receptor Agonist Market Forecast 2026–2036: Market Expansion Driven by Cardiometabolic DemandsThe global GLP-1 receptor agonist market is projected to witness strong expansion over the next decade, supported by widening clinical indications and rapid pharmaceutical innovation. The market is expected to grow steadily, reaching approximately USD 7.8 billion by 2036, registering a CAGR of 11.7%, according to the latest analysis by Future Market Insights (FMI). Market growth is...0 Comments 0 Shares 448 Views 0 Reviews
-
Long-Acting Implantable GLP-1 Obesity Devices Market Growth, Global Outlook, Analysis, Trends and Forecast Analysis By FMINEWARK, DE |—The long-acting implantable GLP-1 obesity devices market is valued at USD 59.1 million in 2025 and is projected to reach USD 76.0 million in 2026. Expanding at a robust CAGR of 28.50%, the market is expected to surge to USD 932.9 million by 2036. This growth reflects a fundamental shift in obesity care delivery, as stakeholders prioritize long-term therapy...0 Comments 0 Shares 358 Views 0 Reviews
-
Nutritive Sweetener Market to Reach USD 39.97 Billion by 2036 Driven by Natural-Source Formulations, Fructose Growth, and Compact GLP-1 NutritionThe global nutritive sweetener market is undergoing a structural bifurcation, according to latest insights by Future Market Insights. While bulk commodity sweeteners like High-Fructose Corn Syrup (HFCS) face volume headwinds from sugar taxes and health-conscious reformulations in mature Western economies, emerging markets across South and Southeast Asia are driving steady caloric sweetener...0 Comments 0 Shares 397 Views 0 Reviews
-
Obesity-Related Malnutrition Nutrition Market Set to Reach USD 634.0 Million by 2036 as GLP-1 Pharmacotherapy and Rapid Weight Loss Drive Demand for Lean-Mass-Preserving Medical FormulationsHigh-protein, low-calorie oral nutritional supplements (ONS) are projected to capture 43.3% of product type demand in 2026, as the global obesity-related malnutrition nutrition market expands from USD 242.2 million in 2026 to USD 634.0 million by 2036, according to the latest research report published by Future Market Insights. The obesity-related malnutrition nutrition market is...0 Comments 0 Shares 217 Views 0 Reviews
-
Emerging Opportunities in GLP-1 Drug DevelopmentValued at USD 61.89 billion in 2025, the GLP-1 Receptor Agonist Market is estimated at USD 70.21 billion in 2026 and is projected to reach USD 257.12 billion by 2034, registering a CAGR of 17.14% during 2026–2034. North America led the market in 2025 with a 75.46% revenue share, while Asia Pacific is projected to grow at a 14.1% CAGR. Ozempic accounted for 32.15% of the market in 2025....0 Comments 0 Shares 44 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek